The DNA damage-dependent intra–S phase checkpoint is regulated by parallel pathways
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
To preserve genetic integrity, mammalian cells exposed to ionizing radiation activate the ATM kinase, which initiates a complex response-including the S-phase checkpoint pathways-to delay DNA replication. Defects in ATM or its substrates Nbs1 or Chk2 (ref. 3), the Nbs1-interacting Mre11 protein, or the Chk2-regulated Cdc25A-Cdk2 cascade all cause radio-resistant DNA synthesis (RDS). It is unknown, however, whether these proteins operate in a common signaling cascade. Here we show that experimental blockade of either the Nbs1-Mre11 function or the Chk2-triggered events leads to a partial RDS phenotype in human cells. In contrast, concomitant interference with Nbs1-Mre11 and the Chk2-Cdc25A-Cdk2 pathways entirely abolishes inhibition of DNA synthesis induced by ionizing radiation, resulting in complete RDS analogous to that caused by defective ATM. In addition, Cdk2-dependent loading of Cdc45 onto replication origins, a prerequisite for recruitment of DNA polymerase, was prevented upon irradiation of normal or Nbs1/Mre11-defective cells but not cells with defective ATM. We conclude that in response to ionizing radiation, phosphorylations of Nbs1 and Chk2 by ATM trigger two parallel branches of the DNA damage-dependent S-phase checkpoint that cooperate by inhibiting distinct steps of DNA replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, different treatment protocols may account for the discrepancy between the A-T-like phenotype of A-TLD(S) cells observed by us and the moderate cellular phenotype reported for these cells by Stewart et al. (1999) and Falck et al. (2002).”
From Requirement of the MRN complex for ATM activation by DNA damage (2003) · cites this paper as Falck et al. (2002)
Citations
Cites
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939 · cited 1×
“Moreover, as components of both the ATM-Nbs1-Mre11 and the ATM-Chk2-Cdc25A-cyclin E/Cdk2 branches are mutated or deregulated in cance”
BackgroundDNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085 · cited 1×
“, or the Chk2-regulated Cdc25A-Cdk2 cascade all cause radio-resistant DNA synthesis (RDS”
BackgroundSelf-citationStewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060 · cited 1×
“, or the Chk2-regulated Cdc25A-Cdk2 cascade all cause radio-resistant DNA synthesis (RDS”
BackgroundSelf-citation(1999) · PubMed · Cited by 1,030
Méndez, J., & Stillman, B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8602-8612.2000 · Cited by 915 · cited 1×
“We isolated chromatin from U-2-OS/VP16 cells and lymphoblasts as describe”
MethodAtaxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 829
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 789 · cited 1×
“The nexus of S-phase regulation seems to be the origin, as in normal cells, DNA damage induces the inhibition of DNA replication origins while ongoing DNA replication forks are not affecte”
BackgroundATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
Lim, D.-S., Kim, S.-T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H. J., & Kastan, M. B. (2000) · Nature · doi:10.1038/35007091 · Cited by 786 · cited 1×
“Either the entire intra–S phase checkpoint, the Nbs1-Mre11 or the Chk2-Cdc25A-Cdk2 branch can be blocked by ectopic ATM-k”
BackgroundSelf-citationThe many substrates and functions of ATM.
Kastan, M. B., & Lim, D.-S. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043058 · Cited by 779
Cited by
Items 101–200 of 401
Mrc1 Is Required for Sister Chromatid Cohesion To Aid in Recombination Repair of Spontaneous Damage
Xu, H., Boone, C., & Klein, H. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7082-7090.2004 · Cited by 106
“cerevisiae (16, 51), and Mre11 is the key player in checkpoint signaling (7, 34, 50).”
BackgroundEndoplasmic Reticulum Stress, Genome Damage, and Cancer
Dicks, N., Gutierrez, K., Michalak, M., Bordignon, V., & Agellon, L. B. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00011 · Cited by 104
“ATM and ATR also activate the serine–threonine checkpoint effector kinases, Chk1 and Chk2, which regulate a number of proteins involved in transcription, cell cycle progression and apoptosis, including the tumor suppressor protein p53 and BRCA1 (41, 42), and the cell cycle regulator proteins Cdc25 and Wee1 (43, 44).”
BackgroundCdk2 is required for p53-independent G2/M checkpoint control
Chung, J. H., & Bunz, F. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000863 · Cited by 105
Regulation of the cellular DNA double-strand break response
Cann, K. L., & Hicks, G. G. (2007) · Biochemistry and Cell Biology · doi:10.1139/o07-135 · Cited by 101
“2004), although it is not through Cdc45 loading (Falck et al. 2002).”
BackgroundRegulation of DNA replication by the S-phase DNA damage checkpoint
Willis, N. A., & Rhind, N. (2009) · Cell Division · doi:10.1186/1747-1028-4-13 · Cited by 129
“These observations suggest the ATM RDS phenotype is due to defects in origindependent and independent, presumably fork slowing, events.”
BackgroundInfluentialCell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12520 · Cited by 107
Liu, P., Barkley, L. R., Day, T., Bi, X., Slater, D. M., Alexandrow, M. G., Nasheuer, H.-P., & Vaziri, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602982200 · Cited by 98
DNA damage responses and their many interactions with the replication fork
Andreassen, P. R., Ho, G. P. H., & D’Andrea, A. D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi319 · Cited by 114
Xiao, Z., Xue, J., Sowin, T. J., & Zhang, H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0077 · Cited by 110
The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer
Mazumdar, T., DeVecchio, J., Agyeman, A., Shi, T., & Houghton, J. A. (2011) · Oncotarget · doi:10.18632/oncotarget.310 · Cited by 97
“The cell cycle checkpoints constitute a regulatory mechanism to arrest the cell cycle in response to DNA damage so that cell cycle progression and repair may be temporally coordinated[39-42].”
BackgroundXie, C., Drenberg, C. D., Edwards, H. J., Caldwell, J. T., Chen, W., Inaba, H., Xu, X., Buck, S. A., Taub, J. W., Baker, S. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079106 · Cited by 99
DNA Methyltransferase 1 Knockdown Activates a Replication Stress Checkpoint
Unterberger, A., Andrews, S. D., Weaver, I. C. G., & Szyf, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01887-05 · Cited by 109
“CDC25a phosphatase activity is required for activation of CDC45 (7); thus, degradation of CDC25a leads to decreased CDC45 loading onto the replication origin (data not shown).”
BackgroundInfluentialTse, A. N., & Schwartz, G. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0841 · Cited by 92
“appears to be mediated in trans by several checkpoint kinases, including ATM, ATR, chk1, and chk2 (6, 8, 48, 49).”
BackgroundCHEK2 contribution to hereditary breast cancer in non-BRCAfamilies
Desrichard, A., Bidet, Y., Uhrhammer, N. A., & Bignon, Y. (2011) · Breast Cancer Research · doi:10.1186/bcr3062 · Cited by 93
Genetic instability in cancer cells by impaired cell cycle checkpoints
Nakanishi, M., Shimada, M., & Niida, H. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00289.x · Cited by 105
Genetic contributions to Parkinson's disease
Huang, Y. M., Cheung, L., Rowe, D. B., & Halliday, G. M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.007 · Cited by 110
“ATM is the sensor for DNA damage and controls cell cycle checkpoint signaling pathways to maintain genome integrity [66,67,144,270,298].”
BackgroundATP Activates Ataxia-Telangiectasia Mutated (ATM) in Vitro
Kozlov, S., Gueven, N., Keating, K., Ramsay, J., & Lavin, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300003200 · Cited by 92
Methylator-induced, Mismatch Repair-dependent G2Arrest Is Activated through Chk1 and Chk2
Adamson, A. W., Beardsley, D. I., Kim, W.-J., Gao, Y., Baskaran, R., & Brown, K. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-02-0089 · Cited by 88
“Phosphorylation of Cdc25A triggers ubiquitin-dependent degradation of Cdc25A and forms the molecular basis for the S-phase checkpoint (Mailand et al., 2000; Falck et al., 2002).”
BackgroundOlson, E., Nievera, C. J., Lee, A. Y.-L., Chen, L., & Wu, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702162200 · Cited by 82
The two edges of the ATM sword: Co-operation between repair and checkpoint functions
Löbrich, M., & Jeggo, P. A. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.027 · Cited by 95
“[30] Falck J, Petrini JH, Williams BR, Lukas J, Bartek J.”
BackgroundATM is required for the cellular response to thymidine induced replication fork stress
Bolderson, E., Scorah, J., Helleday, T., Smythe, C., & Meuth, M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh316 · Cited by 86
“A tumour cell line defective in Chk2 function also appears to be defective in the IR-induced DNA synthesis delay (8), however, primary mouse fibroblasts obtained from Chk22/2 knockout mice retain this S-phase checkpoint (11).”
BackgroundDNA Damage Induces p53-dependent BRCA1 Nuclear Export
Feng, Z., Kachnic, L. A., Zhang, J., Powell, S. N., & Xia, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404137200 · Cited by 92
“BRCA1 function is regulated by a variety of mechanisms including transcription (6), phosphorylation (7,8), and protein-protein interaction(9-11), and nuclear foci formation(12,13).”
BackgroundThe Mre11 Complex Mediates the S-Phase Checkpoint through an Interaction with Replication Protein A
Olson, E., Nievera, C. J., Liu, E., Lee, A. Y.-L., Chen, L., & Wu, X. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00532-07 · Cited by 81
“The ATM/Chk2 and ATM/Nbs1 pathways are two parallel pathways required to mediate the intraS-phase checkpoint (16).”
BackgroundIndependent Roles for Nibrin and Mre11-Rad50 in the Activation and Function of Atm
Cerosaletti, K., & Concannon, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404294200 · Cited by 83
Cdc7-Dbf4 and the Human S Checkpoint Response to UVC
Heffernan, T. P., Ünsal-Kaçmaz, K., Heinloth, A. N., Simpson, D. A., Paules, R. S., Sancar, A., Cordeiro‐Stone, M., & Kaufmann, W. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611292200 · Cited by 100
The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage
Lee, J.-H., Kang, Y. J., Khare, V., Jin, Z.-Y., Kang, M.-Y., Yoon, Y. M., Hyun, J.-W., Chung, M.-H., Cho, S.-I., Jun, J. Y., et al. (2009) · Oncogene · doi:10.1038/onc.2009.438 · Cited by 85
Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?
van den Bosch, T., Kılıç, E., Paridaens, D. A., & de Klein, A. (2010) · Dermatology Research and Practice · doi:10.1155/2010/360136 · Cited by 83
“The encoded protein product is postulated to be part of a complex involved in DNA-repair [102].”
BackgroundBeccafico, S., Morozzi, G., Marchetti, M. C., Riccardi, C., Sidoni, A., Donato, R., & Sorci, G. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv098 · Cited by 79
Demuth, I., Frappart, P., Hildebrand, G., Melchers, A., Lobitz, S., Stöckl, L., Varon, R., Herceg, Z., Sperling, K., Wang, Z., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh278 · Cited by 91
“Phosphorylated nibrin facilitates the ATM-mediated phosphorylation of further target molecules, such as CHK2, CHK1 and SMC1, involved in key steps of the cell cycle, including entry into mitosis (14,15).”
BackgroundThe role of ATM in breast cancer development
Prokopcova, J., Kleibl, Z., Banwell, C. M., & Pohlreich, P. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9406-6 · Cited by 94
“Moreover, Chk2 was confirmed to play a role in the S-phase checkpoint [34].”
BackgroundThe role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia
Stanković, T., & Skowrońska, A. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.829919 · Cited by 86
Pontano, L. L., Aggarwal, P., Barbash, O., Brown, E. J., Bassing, C. H., & Diehl, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01085-08 · Cited by 71
“The primary mechanism of DSB-induced S-phase arrest involves inhibition of unfired replication origins (6, 16, 19 ).”
BackgroundSunavala‐Dossabhoy, G., & Benedetti, A. D. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.005 · Cited by 78
The fork and the kinase: A DNA replication tale from a CHK1 perspective
González Besteiro, M. A., & Gottifredi, V. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.10.003 · Cited by 69
“Also in support of such model, Chk1-dependent reduction in Cdc45 binding to chromatin has been observed previously [7,101,102].”
BackgroundCerosaletti, K. M., & Concannon, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211689200 · Cited by 74
Składanowski, A., Bozko, P. M., & Sabisz, M. (2009) · Chemical Reviews · doi:10.1021/cr900026u · Cited by 77
NBS1 Expression as a Prognostic Marker in Uveal Melanoma
Ehlers, J. P., & Harbour, J. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2054 · Cited by 75
The Fission Yeast Rad32 (Mre11)-Rad50-Nbs1 Complex Is Required for the S-Phase DNA Damage Checkpoint
Chahwan, C., Nakamura, T. M., Sivakumar, S., Russell, P., & Rhind, N. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6564-6573.2003 · Cited by 75
“In contrast, other studies that examined the role of Nbs1 and Mre11 in the activation of Cds1 and ATM found no requirement (16, 35, 71).”
ResultThe S-phase checkpoint and its regulation in Saccharomyces cerevisiae
Longhese, M. P., Clerici, M., & Lucchini, G. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2003.08.009 · Cited by 90
Drosophila melanogaster: a Model for the Study of DNA Damage Checkpoint Response
Song, Y. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13152-9 · Cited by 79
Zhao, S. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf612 · Cited by 71
“the G1/S checkpoint, G2/M checkpoint and a parallel Chk2-dependent S phase checkpoint (41), can be activated upon DNA damage, abrogation of one checkpoint may not be suf®cient to cause hypersensitivity to IR.”
BackgroundCritical Role for Mouse Hus1 in an S-Phase DNA Damage Cell Cycle Checkpoint
Weiss, R. S., Leder, P., & Vaziri, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.791-803.2003 · Cited by 83
“Several Atm substrates, including Nbs1 (19, 35, 61, 68), Brca1 (62), Chk2 (15), and Smc1 (32, 65) are also required for repression of DNA synthesis after IR and act cooperatively in parallel signaling pathways downstream of Atm (16).”
BackgroundIs low-dose hyper-radiosensitivity a measure of G2-phase cell radiosensitivity?
Marples, B. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031761.61361.2a · Cited by 76
“The role of the S-phase checkpoint is to halt the replication of damaged DNA [56].”
BackgroundAutophosphorylation of Checkpoint Kinase 2 at Serine 516 Is Required for Radiation-induced Apoptosis
Wu, X., & Chen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303795200 · Cited by 67
Regulation of the Life Cycle of HPVs by Differentiation and the DNA Damage Response
Hong, S., & Laimins, L. A. (2013) · Future Microbiology · doi:10.2217/fmb.13.127 · Cited by 75
Xu, Z.-Y., Loignon, M., Han, F.-Y., Panasci, L., & Aloyz, R. S. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084053 · Cited by 69
“The DNA damageactivated kinases Chk1 and Chk2 are also implicated in regulation of G2 checkpoints (Falck et al., 2002). p53 has been shown as well to be an important component of G1 and G2 arrest in response to DNA damage.”
BackgroundProtein Phosphatase 2A Antagonizes ATM and ATR in a Cdk2- and Cdc7-Independent DNA Damage Checkpoint
Petersen, P., Chou, D. M., You, Z., Hunter, T. R., Walter, J. C., & Walter, G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1997-2011.2006 · Cited by 79
“An ATM-dependent, Cdk2-independent G1/S checkpoint, which operates through a complex of Nijmegen breakage syndrome protein 1 (Nbs1) and the Nbs1-interacting proteins Mre11 and Rad50, was discovered in mammalian cells (13).”
BackgroundN Terminus of CtIP Is Critical for Homologous Recombination-mediated Double-strand Break Repair
Yuan, J., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023424 · Cited by 66
Lindqvist, A., Källström, H., & Karlsson, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01395 · Cited by 75
“All three human Cdc25 isoforms are suggested targets of checkpoint pathways: Cdc25A is degraded at the S-phase DNA-replication checkpoint via Chk1and Chk2-mediated phosphorylation (Falck et al., 2001; Falck et al., 2002; Zhao et al., 2002).”
BackgroundThe S phase checkpoint: When the crowd meets at the fork
GOTTIFREDI, V, & PRIVES, C. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.02.011 · Cited by 68
Matsuya, Y., McMahon, S. J., Tsutsumi, K., Sasaki, K., Okuyama, G., Yoshii, Y., Mori, R., Oikawa, J., Prise, K. M., & Date, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-26556-5 · Cited by 65
Lee, J., Xu, B., Lee, C. H., Ahn, J.-Y., Song, M. S., Lee, H., Canman, C. E., Lee, J., Kastan, M. B., & Lim, D. (2003) · PubMed · Cited by 75
Chk2 Suppresses the Oncogenic Potential of DNA Replication-Associated DNA Damage
Stracker, T. H., Couto, S. S., Cordon‐Cardo, C., Matos, T., & Petrini, J. H. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.028 · Cited by 69
“Genetic Interactions between the Mre11 Complex and Chk2 We previously established evidence that Nbs1 and Chk2 acted in parallel pathways to regulate the intra-S phase checkpoint (Falck et al., 2002).”
BackgroundInfluentialSelf-citationEDD Mediates DNA Damage-induced Activation of CHK2
Henderson, M. J., Munoz, M. A., Saunders, D. N., Clancy, J. L., Russell, A. J., Williams, B. L., Pappin, D., Khanna, K. K., Jackson, S. P., Sutherland, R. L., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602818200 · Cited by 73
Self-citationSTAT-1 facilitates the ATM activated checkpoint pathway following DNA damage
Townsend, P. A., Cragg, M. S., Davidson, S. M., McCormick, J., Barry, S. P., Lawrence, K. M., Knight, R. A., Hubank, M. J. F., Chen, P., Latchman, D. S., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.01728 · Cited by 69
“both G1-S phase and G2-M transition checkpoint-control (Abraham, 2001; Falck et al., 2001; Falck et al., 2002; Bartek and Lukas, 2003; Shiloh, 2003), whereas Chk2-p53, Chk2-”
BackgroundRetractedBudzowska, M., Jaspers-Dekker, I., Essers, J., de Waard, H., van Drunen, E., Hanada, K., Beverloo, B., Hendriks, R. W., de Klein, A., Kanaar, R., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600353 · Cited by 62
Heinloth, A. N., Shackelford, R. E., Innes, C. L., Bennett, L., Li, L., Amin, R. P., Sieber, S. O., Flores, K. G., Bushel, P. R., & Paules, R. S. (2003) · Radiation Research · doi:10.1667/rr3047 · Cited by 62
Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy
Maugeri‐Saccà, M., Bartucci, M., & Maria, R. D. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.10.007 · Cited by 64
Rad50 depletion impacts upon ATR-dependent DNA damage responses
Zhong, H., Bryson, A., Eckersdorff, M., & Ferguson, D. O. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi302 · Cited by 61
“Inhibition of DNA synthesis after UV or g radiation was assessed as described previously (54).”
MethodERK activity facilitates activation of the S-phase DNA damage checkpoint by modulating ATR function
Wu, D., Chen, B., Parihar, K., He, L., Fan, C., Zhang, J., Liu, L., Gillis, A. M., Bruce, A., Kapoor, A., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209148 · Cited by 68
“At the highest dose used (1mM), HU reduced DNA synthesis in MCF7 cells by approximately 50% when assayed by the standard [3H]:[14C] methodology (data not shown) (Stewart et al., 1999; Falck et al., 2002).”
MethodPalle, K., & Vaziri, C. (2011) · Cell Cycle · doi:10.4161/cc.10.10.15617 · Cited by 69
“49,50 We consistently observed an increase in chromatin loading of replication factors after CPT washout in the FANCD2 and Rad18-replete (siCon) cultures.”
Jin, J., Ang, X. L., Ye, X., Livingstone, M., & Harper, J. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802474200 · Cited by 57
Girard, P.-M., Pozzebon, M. E., Delacôte, F., Douki, T., Smirnova, V., & Sage, É. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.05.004 · Cited by 59
The ATM-SMC1 pathway is essential for activation of the chromium[VI]-induced S-phase checkpoint
Wakeman, T. P., Kim, W.-J., Callens, S., Chiu, A. O. S., Brown, K. D., & Xu, B. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.006 · Cited by 60
Nijmegen breakage syndrome and DNA double strand break repair by NBS1 complex
Matsuura, S., Kobayashi, J., TAUCHI, H., & KOMATSU, K. (2004) · Advances in Biophysics · doi:10.1016/s0065-227x(04)80076-5 · Cited by 60
Expanded Roles for Chk1 in Genome Maintenance
Enders, G. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800021200 · Cited by 56
The human intra-S checkpoint response to UVC-induced DNA damage
Kaufmann, W. K. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp230 · Cited by 52
Ismail, I. A., Kang, K.-S., Lee, H. A., Kim, J.-W., & Sohn, Y. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.07.039 · Cited by 59
Gene Expression Profiling of the Irinotecan Pathway in Colorectal Cancer
Yu, J., Shannon, W. D., Watson, M. A., & McLeod, H. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1254 · Cited by 55
Bernstein, J. L., Teraoka, S. N., John, E. M., Andrulis, I. L., Knight, J. A., Lapinski, R. H., Olson, E. R., Wolitzer, A. L., Seminara, D., Whittemore, A. S., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0557 · Cited by 54
“On activation, CHEK2 acquires the ability to carry out the following functions: (a) Activated CHEK2 regulates the S-phase cell cycle checkpoint, presumably by phosphorylating CDC25A (4, 5).”
BackgroundInfluentialMeng, X. W., Chandra, J., Loegering, D., Van Becelaere, K., Kottke, T. J., Gore, S. D., Karp, J. E., Sebolt-Leopold, J., & Kaufmann, S. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304793200 · Cited by 54
Dzikiewicz‐Krawczyk, A. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.05.005 · Cited by 55
Chen, C.-R., Wang, W., Rogoff, H. A., Li, X., Mang, W., & Li, C. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0677 · Cited by 52
“Inhibitors of Chk2 and other checkpoint kinases are now in preclinical and clinical development as sensitizers for chemotherapy (1, 2, 10).”
BackgroundCell cycle control, DNA damage checkpoints and cancer
Laiho, M., & Latonen, L. (2003) · Annals of Medicine · doi:10.1080/07853890310014605 · Cited by 59
“The MREll complex enforces a parallel intra S phase dependent checkpoint which acts together with Chk2-Cdc25A-Cdk2 to mediate S-phase arrest (39) (Fig 2 .”
Early Events in the DNA Damage Response
Ward, I. M., & Chen, J. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)63001-8 · Cited by 58
Jayachandran, G., Ueda, K., Wang, B., Roth, J. A., & Ji, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011994 · Cited by 52
Iyer, D., & Rhind, N. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006958 · Cited by 54
“cerevisiae [9] and human cells [7,8,15] reduction in origin firing in response to 4NQO, bleomycin and MMS is checkpoint-dependent.”
Porcedda, P., Turinetto, V., Lantelme, E., Fontanella, E., Chrzańowska, K., Ragona, R., Marchi, M., Delia, D., & Giachino, C. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.002 · Cited by 54
Functional classification of ATM variants in ataxia‐telangiectasia patients
Fiévet, A., Bellanger, D., Rieunier, G., d’Enghien, C. D., Julia, S., Calvas, P., Carriere, J., Anheim, M., Castrioto, A., Flabeau, O., et al. (2019) · Human Mutation · doi:10.1002/humu.23778 · Cited by 46
DNA Damage Checkpoints and Cancer
Shimada, M., & Nakanishi, M. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9039-4 · Cited by 54
“The intra-S checkpoint is regulated by two distinct pathways, namely ATM/ATR–Chk1/Chk2– CDC25A and ATM–NBS1–SMC1 (Falck et al. 2002).”
BackgroundATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven
Wang, J., Wiltshire, T. D., Wang, Y., Mikell, C., Burks, J., Cunningham, C., Laar, E. S. V., Waters, S. J., Reed, E., & Wang, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400015200 · Cited by 48
Coordination of Repair, Checkpoint, and Cell Death Responses to DNA Damage
Wang, J. Y. J., & Cho, S. K. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)69004-8 · Cited by 46
Molecular Pathobiology of Uveal Melanoma
Ehlers, J. P., & Harbour, J. W. (2005) · International Ophthalmology Clinics · doi:10.1097/01.iio.0000195855.31324.db · Cited by 45
“The protein encoded by the NBS1 (Nijmegen breakage syndrome 1) gene is a part of a complex that is involved in DNA damage repair.(36) Potentially, upregulation of NBS1 could allow uveal melanoma progression by promoting the repair of DNA damage, which occurs more frequently in advanced tumors with increased genomic in…”
BackgroundHCLK2 Is Required for Activity of the DNA Damage Response Kinase ATR
Danielsen, J. M. R., Larsen, D. H., Schou, K. B., Freire, R., Falck, J., Bártek, J., & Lukas, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808174200 · Cited by 53
Self-citationDas, U. N., & Rao, K. P. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.01.002 · Cited by 42
“of deoxyguanosine to form a bulky hydrophobic adduct [5].”
BackgroundTichý, A., Vávrová, J., Pejchal, J., & Řezáčová, M. (2010) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2016.57 · Cited by 43
“The same group also proved that a parallel mechanisms, by which ATM controls S-checkpoint, exists – demanding MRN complex (15).”
BackgroundSMC1-Mediated Intra-S-Phase Arrest Facilitates Bocavirus DNA Replication
Luo, Y., Deng, X., Cheng, F., Li, Y., & Qiu, J. (2013) · Journal of Virology · doi:10.1128/jvi.03396-12 · Cited by 41
Interactions between radiation and endocrine therapy in breast cancer.
Schmidberger, H., Hermann, R. M., Hess, C. F., & Emons, G. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100375 · Cited by 44
Checkpoint Mediators: Relaying Signals from DNA Strand Breaks
Canman, C. E. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00410-x · Cited by 47
“Chk2 is considered a major effector of ATM, acting to promote degradation of the phosphatase Cdc25A and thereby prevent activation of the cyclindependent kinase Cdk2 and initiation of DNA replication [9].”
Quality control of homologous recombination
Liu, T., & Huang, J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1649-5 · Cited by 44
Domenico, E. G. D., Romano, E., Porto, P. D., & Ascenzioni, F. (2014) · BioMed Research International · doi:10.1155/2014/787404 · Cited by 44
“These include CHK1 and CHK2, which phosphorylate CDC25A, to cause inhibition of CDK2 activity and cell-cycle arrest [130].”
BackgroundTargeted gene repair activates Chk1 and Chk2 and stalls replication in corrected cells
Ferrara, L., & Kmiec, E. B. (2006) · DNA repair · doi:10.1016/j.dnarep.2005.11.009 · Cited by 41
G1 and S-Phase Checkpoints, Chromosome Instability, and Cancer
Nojima, H. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:003 · Cited by 48
Lin, Z. P., Belcourt, M. F., Carbone, R., Eaton, J. S., Penketh, P. G., Shadel, G. S., Cory, J. G., & Sartorelli, A. C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.014 · Cited by 41
ATM activation in hypoxia - causes and consequences
Olcina, M. M., Grand, R. J. A., & Hammond, E. M. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29903 · Cited by 41
“Degradation of CDC25A after CHK1/CHK2dependent phosphorylation maintains CDK2 in its inactive phosphorylated state thereby precluding the loading of CDC45 on DNA replication origins.(39,40)”
BackgroundGenetics and RNA Regulation of Uveal Melanoma
Barbagallo, C., Stella, M., Broggi, G., Russo, A., Caltabiano, R., & Ragusa, M. (2023) · Cancers · doi:10.3390/cancers15030775 · Cited by 38
Parvovirus-Induced Depletion of Cyclin B1 Prevents Mitotic Entry of Infected Cells
Adeyemi, R. O., & Pintel, D. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003891 · Cited by 39
“Following IR treatment, inactivation of either the Chk2-CDC25A pathway or the SMC1 pathway alone results in a partial radio-resistant DNA synthesis (RDS) phenotype - a scenario in which a reduced level of DNA synthesis still takes place following radiation treatment [51].”
BackgroundMethodKnockout mice provide novel insights into meiotic chromosome and telomere dynamics
Scherthan, H. (2003) · Cytogenetic and Genome Research · doi:10.1159/000076809 · Cited by 42
“However, Chk2 knockout mice are viable and fertile (Takai et al., 2002) but show defects in DNA damage induced apoptosis and in the intra S-checkpoint (Falck et al., 2002).”
BackgroundPark, S.-Y., Im, J., Park, S.-R., Kim, S.-E., Wang, H.-J., & Lee, J.-K. (2012) · Cell Cycle · doi:10.4161/cc.11.4.19209 · Cited by 36
Aris, S. M., & Pommier, Y. G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2579 · Cited by 37
“Although Chk1 is the predominant kinase that affects S-phase progression, Chk2 has been shown to participate in the S-phase response after UV treatment (46).”
Background
Metadata
- Authors
- Falck, J., Petrini, J. H. J., Williams, B. R., Lukas, J., & Bartek, J.
- Affiliations
- Danish Cancer Society (DK)
- University of Wisconsin–Madison (US)
- Venue
- Nature Genetics
- Published
- 2002-02-19
- Volume
- 30
- Issue
- 3
- Pages
- 290-294
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2104788350
- Cited by
- 392
- References
- 30
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 8 · 2016: 7 · 2015: 11 · 2014: 13 · 2013: 16 · 2012: 16
- FWCI
- 15.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- S-phase checkpoint, DNA damage response, ionizing radiation, ATM kinase, NBS1, MRE11, Chk2, CDC25A, CDK2, radioresistant DNA synthesis, DNA replication, parallel signaling pathways, Chk2 phosphorylation
- MeSH terms
- Cell Line, DNA Damage, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Kinases, Radiation, Ionizing, S Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, cdc25 Phosphatases, Tumor Suppressor Proteins, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase 2, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.